ArticleDiagnostics (Basel, Switzerland)2026
Differential Serum MicroRNA Profiling in Benign and Malignant Ovarian Tumours: An Exploratory Study Identifying hsa-miR-200c-3p as a Candidate Diagnostic Biomarker.
Jose D Santotoribio, Juan Corral-Perez, Laura Avila-Cabeza-de-Vaca, Manuel Costilla, María Mayor-Reyes, Daniel Fatela-Cantillo, Jose M Silvan, Cristina Casals, Jesus G Ponce-Gonzalez, Pablo Mesa-Suarez and 2 more
Abstract read
In one paragraphArticle in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Jose D SantotoribioDepartment of Laboratory Medicine, Puerto Real University Hospital, 11510 Cadiz, Spain.ORCID 0000-0002-8851-7551 Juan Corral-PerezInstitute for Biomedical Research and Innovation of Cádiz (INiBICA), 11003 Cadiz, Spain.
Laura Avila-Cabeza-de-VacaInstitute for Biomedical Research and Innovation of Cádiz (INiBICA), 11003 Cadiz, Spain.
Manuel CostillaInstitute for Biomedical Research and Innovation of Cádiz (INiBICA), 11003 Cadiz, Spain.ORCID 0009-0008-8095-8521 María Mayor-ReyesDepartment of Laboratory Medicine, Puerto Real University Hospital, 11510 Cadiz, Spain.ORCID 0000-0002-6385-4439 Daniel Fatela-CantilloDepartment of Laboratory Medicine, Virgen del Rocío University Hospital, 41013 Seville, Spain.
Jose M SilvanDepartment of Obstetrics and Gynecology, Virgen del Rocío University Hospital, 41013 Seville, Spain.
Cristina CasalsInstitute for Biomedical Research and Innovation of Cádiz (INiBICA), 11003 Cadiz, Spain.ORCID 0000-0002-6992-0492 Jesus G Ponce-GonzalezInstitute for Biomedical Research and Innovation of Cádiz (INiBICA), 11003 Cadiz, Spain.
Pablo Mesa-SuarezInstitute for Biomedical Research and Innovation of Cádiz (INiBICA), 11003 Cadiz, Spain.
Carmen González MacíasInstitute for Biomedical Research and Innovation of Cádiz (INiBICA), 11003 Cadiz, Spain.
Juan Jesús Fernández AlbaInstitute for Biomedical Research and Innovation of Cádiz (INiBICA), 11003 Cadiz, Spain.ORCID 0000-0002-7297-6876 Funding
Junta de Andalucía PIP-0160-2022
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
adnexal masscirculating microRNAdiagnostic biomarkerhsa-miR-200c-3pliquid biopsyovarian carcinoma
Identifiers
PMID42739150
PMCPMC13565031
What OpenQuestion holds
Textmetadata
Read underepoch 390